Question 1

What are the potential benefits of participating in this trial for my heart health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy clinical trial (NCT06844669). Contact the study team or your healthcare provider for specific answers.

Question 2

How do carvedilol and empagliflozin work to prevent heart issues?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy clinical trial (NCT06844669). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of these medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy clinical trial (NCT06844669). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my participation in this trial affect my current cancer treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy clinical trial (NCT06844669). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy clinical trial (NCT06844669). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any other treatment options I should consider alongside this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy clinical trial (NCT06844669). Contact the study team or your healthcare provider for specific answers.

What this study is about